A brief battery for the evaluation of cognitive deficits in italian SLE patients
2005-01-01 Tomietto, P; Annese, V; Venturini, P; Tolusso, B; Gremese, E; Ferraccioli, G
CD19+ZAP70+ B cells value at baseline predicts response at T6 to BCDT (B cell depletion therapy). Recovery is mainly characterized by the appearance of naïve activated B cells and ZAP-70 positive B cells
2011-01-01 Faustini, F; Tolusso, B; Peluso, G; Gremese, E; Canestri, S; D'Antona, G; Laria, A; Ferraccioli, G
Hepatocyte growth factor (HGF)/transforming growth factor (TGF-BETA1) balance in renal biopsies and clinical outcome in patients with lupus nephritis treated with cyclophosphamide
2005-01-01 Peluso, G; Capuano, A; Costanzi, S; Zannoni, G; Vellone, Vg; Gremese, E; Zoli, A; Ferraccioli, G
Integrin alpha2bbeta3 gene polymorphism and the microvascular system in scleroderma
2004-01-01 Tolusso, B; Franzolini, N; Fabris, M; Gremese, E; Di Poi, E; Cuomo, G; Valentini, G; Ferraccioli, G
Hepatocyte growth factor (HGF)/transforming growth factor (TGF-BETA1) balance in renal biopsies and clinical outcome in patients with lupus nephritis treated with cyclophosphamide
2005-01-01 Peluso, G; Capuano, A; Costanzi, S; Zannoni, G; Vellone, Vg; Gremese, E; Zoli, A; Ferraccioli, G
Balance between hepatocyte growth factor (HGF) and transforming growth factor (TGF-BETA1) in renal biopsies of patients with lupus nephritis
2005-01-01 Capuano, A; Peluso, G; Costanzi, S; Zannoni, G; Vellone, Vg; Scott, C; Romano, G; Gremese, E; Zoli, A; Ferraccioli, G
Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting
2016-01-01 Siano, ; Infante, ; Miceli, ; Resteghini, C; Locati, ; Licitra, ; Bossi,
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN).
2017-01-01 Pai, ; Sara, I.; Cohen, ; Ezra, ; Lin, ; Derrick, ; Fountzilas, ; George, ; Kim, ; Edward, S.; Mehlhorn, ; Holger, ; Baste, ; Neus, ; Clayburgh, ; Daniel, ; Lipworth, ; Loren, ; Resteghini, C; Shara, ; Nawar, ; Fujii, ; Takashi, ; Zhang, ; Jun, ; Stokes, ; Michael, ; Lawrence, ; David, ; Khaliq, ; Asud, ; Melillo, ; Giovanni, ; Shire, ; Norah,
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN)
2018-01-01 Pai, ; Cohen, ; E. E., W.; Lin, ; Fountzilas, ; Kim, ; Mehlhorn, ; Baste, ; Clayburg, ; Lipworth, ; Resteghini, C; Shara, ; Fujii, ; Zhang, ; Stokes, ; Lawrence, ; Khaliq, ; Melillo, ; Shire,
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients
2021-01-01 Corino, ; Valentina, ; Colombo, ; Elena, ; Bologna, ; Marco, ; Calareso, ; Giuseppina, ; Mainardi, ; Luca, ; Cavalieri, ; Stefano, ; Filippini, ; Daria, Maria; Resteghini, C; Bergamini, ; Cristiana, ; Licitra, ; Lisa, F.; Locati, ; Laura, Deborah
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment
2022-01-01 Cavalieri, ; Vener, ; Leblanc, ; Perez, ; L., Lopez; Fico, ; Resteghini, C; Monzani, ; Marton, ; Moreira-Soares, ; Filippidou, ; D., E.; Almeida, ; Bilbao, ; Mehanna, ; Singer, ; Thomas, ; Lacerenza, ; Manfuso, ; Mercalli, ; Martinelli, ; Licitra, ; L., F.
Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI)
2019-01-01 Alfieri, ; Salvatore, ; Ferrara, ; Roberto, ; Calareso, ; Giuseppina, ; Cavalieri, ; Stefano, ; Platini, ; Francesca, ; Mancinelli, ; Moela, ; Resteghini, C; Orlandi, ; Ester, ; Iacovelli, ; Nicola, Alessandro; Ferella, ; Letizia, ; Piazza, ; Cesare, ; Apollonio, ; Giulia, ; Galbiati, ; Donata, ; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Locati, ; Laura, Deborah; Licitra, ; Lisa, F.
A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma
2017-01-01 Bossi, ; Cavalieri, ; Perrone, ; Miceli, ; Ascierto, ; Locati, ; Bergamini, ; Granata, ; Alfieri, ; Resteghini, C; Galbiati, ; Busico, ; Paielli, ; Patuzzo, ; Maurichi, ; Gallino, ; Ruggeri, ; Mariani, ; Palla, ; Licitra,
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC).
2017-01-01 Bossi, ; Paolo, ; Cavalieri, ; Stefano, ; Perrone, ; Federica, ; Miceli, ; Rosalba, ; Ascierto, ; Paolo, Antonio; Locati, ; Laura, D.; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Alfieri, ; Salvatore, ; Resteghini, C; Galbiati, ; Donata, ; Busico, ; Adele, ; Paielli, ; Nicholas, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Gallino, ; Gianfranco, ; Ruggeri, ; Roberta, ; Mariani, ; Luigi, ; Palla, ; Marco, ; Licitra, ; Lisa,
Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients
2019-01-01 Platini, ; Francesca, ; Barretta, ; Francesco, ; Alfieri, ; Salvatore, ; Cavalieri, ; Stefano, ; Resteghini, C; Galbiati, ; Donata, ; Locati, ; Laura, Deborah; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Calareso, ; Giuseppina, ; Iacovelli, ; Nicola, Alessandro; Quattrone, ; Pasquale, ; Incandela, ; Fabiola, ; Bossi, ; Paolo, ; Licitra, ; Lisa, F.
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN)
2017-01-01 Pai, ; Cohen, ; E., E.; Lin, ; Fountzilas, ; Kim, ; E., S.; Mehlhorn, ; Baste, ; Clayburgh, ; Lipworth, ; Resteghini, C; Shara, ; Fujii, ; Zhang, ; Stokes, ; Lawrence, ; Khaliq, ; Melillo, ; Shire,
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials
2019-01-01 De, Cecco; Serafini, ; M., S.; Canevari, ; Penso, ; Nicolai, ; Castelnuovo, ; Benazzo, ; Sponghini, ; Orlandi, ; Vischioni, ; Piazza, ; Resteghini, C; Licitra, ; Bossi,
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts)
2021-01-01 Resteghini, C; Castelnuovo, ; Paolo, ; Nicolai, ; Piero, ; Orlandi, ; Ester, ; Bossi, ; Paolo, ; Vischioni, ; Barbara, ; Schreiber, ; Alberto, ; Iacovelli, ; Nicola, Alessandro; Battaglia, ; Paolo, ; Mattavelli, ; Davide, ; Facchinetti, ; Nadia, ; Gambazza, ; Simone, ; Calareso, ; Giuseppina, ; Ravanelli, ; Marco, ; Facco, ; Carla, ; Tartaro, ; Tiziana, ; Sponghini, ; Andrea, Pietro; Pagella, ; Fabio, ; Mariani, ; Luigi, ; Licitra, ; Lisa, F.
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience
2016-01-01 Granata, ; Bossi, ; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Fallai, ; Guzzo, ; Infante, ; Locati, ; Miceli, ; Mariani, ; Licitra,
Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer
2017-01-01 Orlandi, ; Infante, ; Granata, ; Iacovelli, ; Miceli, ; Cavallo, ; Alfieri, ; Bergamini, ; Resteghini, C; Galbiati, ; Locati, ; Tana, ; Naimo, ; Fallai, ; Licitra, ; Bossi,
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A brief battery for the evaluation of cognitive deficits in italian SLE patients | 1-gen-2005 | Tomietto, P; Annese, V; Venturini, P; Tolusso, B; Gremese, E; Ferraccioli, G | |
| CD19+ZAP70+ B cells value at baseline predicts response at T6 to BCDT (B cell depletion therapy). Recovery is mainly characterized by the appearance of naïve activated B cells and ZAP-70 positive B cells | 1-gen-2011 | Faustini, F; Tolusso, B; Peluso, G; Gremese, E; Canestri, S; D'Antona, G; Laria, A; Ferraccioli, G | |
| Hepatocyte growth factor (HGF)/transforming growth factor (TGF-BETA1) balance in renal biopsies and clinical outcome in patients with lupus nephritis treated with cyclophosphamide | 1-gen-2005 | Peluso, G; Capuano, A; Costanzi, S; Zannoni, G; Vellone, Vg; Gremese, E; Zoli, A; Ferraccioli, G | |
| Integrin alpha2bbeta3 gene polymorphism and the microvascular system in scleroderma | 1-gen-2004 | Tolusso, B; Franzolini, N; Fabris, M; Gremese, E; Di Poi, E; Cuomo, G; Valentini, G; Ferraccioli, G | |
| Hepatocyte growth factor (HGF)/transforming growth factor (TGF-BETA1) balance in renal biopsies and clinical outcome in patients with lupus nephritis treated with cyclophosphamide | 1-gen-2005 | Peluso, G; Capuano, A; Costanzi, S; Zannoni, G; Vellone, Vg; Gremese, E; Zoli, A; Ferraccioli, G | |
| Balance between hepatocyte growth factor (HGF) and transforming growth factor (TGF-BETA1) in renal biopsies of patients with lupus nephritis | 1-gen-2005 | Capuano, A; Peluso, G; Costanzi, S; Zannoni, G; Vellone, Vg; Scott, C; Romano, G; Gremese, E; Zoli, A; Ferraccioli, G | |
| Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting | 1-gen-2016 | Siano, ; Infante, ; Miceli, ; Resteghini, C; Locati, ; Licitra, ; Bossi, | |
| A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN). | 1-gen-2017 | Pai, ; Sara, I.; Cohen, ; Ezra, ; Lin, ; Derrick, ; Fountzilas, ; George, ; Kim, ; Edward, S.; Mehlhorn, ; Holger, ; Baste, ; Neus, ; Clayburgh, ; Daniel, ; Lipworth, ; Loren, ; Resteghini, C; Shara, ; Nawar, ; Fujii, ; Takashi, ; Zhang, ; Jun, ; Stokes, ; Michael, ; Lawrence, ; David, ; Khaliq, ; Asud, ; Melillo, ; Giovanni, ; Shire, ; Norah, | |
| RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN) | 1-gen-2018 | Pai, ; Cohen, ; E. E., W.; Lin, ; Fountzilas, ; Kim, ; Mehlhorn, ; Baste, ; Clayburg, ; Lipworth, ; Resteghini, C; Shara, ; Fujii, ; Zhang, ; Stokes, ; Lawrence, ; Khaliq, ; Melillo, ; Shire, | |
| Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients | 1-gen-2021 | Corino, ; Valentina, ; Colombo, ; Elena, ; Bologna, ; Marco, ; Calareso, ; Giuseppina, ; Mainardi, ; Luca, ; Cavalieri, ; Stefano, ; Filippini, ; Daria, Maria; Resteghini, C; Bergamini, ; Cristiana, ; Licitra, ; Lisa, F.; Locati, ; Laura, Deborah | |
| BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment | 1-gen-2022 | Cavalieri, ; Vener, ; Leblanc, ; Perez, ; L., Lopez; Fico, ; Resteghini, C; Monzani, ; Marton, ; Moreira-Soares, ; Filippidou, ; D., E.; Almeida, ; Bilbao, ; Mehanna, ; Singer, ; Thomas, ; Lacerenza, ; Manfuso, ; Mercalli, ; Martinelli, ; Licitra, ; L., F. | |
| Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) | 1-gen-2019 | Alfieri, ; Salvatore, ; Ferrara, ; Roberto, ; Calareso, ; Giuseppina, ; Cavalieri, ; Stefano, ; Platini, ; Francesca, ; Mancinelli, ; Moela, ; Resteghini, C; Orlandi, ; Ester, ; Iacovelli, ; Nicola, Alessandro; Ferella, ; Letizia, ; Piazza, ; Cesare, ; Apollonio, ; Giulia, ; Galbiati, ; Donata, ; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Locati, ; Laura, Deborah; Licitra, ; Lisa, F. | |
| A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma | 1-gen-2017 | Bossi, ; Cavalieri, ; Perrone, ; Miceli, ; Ascierto, ; Locati, ; Bergamini, ; Granata, ; Alfieri, ; Resteghini, C; Galbiati, ; Busico, ; Paielli, ; Patuzzo, ; Maurichi, ; Gallino, ; Ruggeri, ; Mariani, ; Palla, ; Licitra, | |
| Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC). | 1-gen-2017 | Bossi, ; Paolo, ; Cavalieri, ; Stefano, ; Perrone, ; Federica, ; Miceli, ; Rosalba, ; Ascierto, ; Paolo, Antonio; Locati, ; Laura, D.; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Alfieri, ; Salvatore, ; Resteghini, C; Galbiati, ; Donata, ; Busico, ; Adele, ; Paielli, ; Nicholas, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Gallino, ; Gianfranco, ; Ruggeri, ; Roberta, ; Mariani, ; Luigi, ; Palla, ; Marco, ; Licitra, ; Lisa, | |
| Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients | 1-gen-2019 | Platini, ; Francesca, ; Barretta, ; Francesco, ; Alfieri, ; Salvatore, ; Cavalieri, ; Stefano, ; Resteghini, C; Galbiati, ; Donata, ; Locati, ; Laura, Deborah; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Calareso, ; Giuseppina, ; Iacovelli, ; Nicola, Alessandro; Quattrone, ; Pasquale, ; Incandela, ; Fabiola, ; Bossi, ; Paolo, ; Licitra, ; Lisa, F. | |
| RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN) | 1-gen-2017 | Pai, ; Cohen, ; E., E.; Lin, ; Fountzilas, ; Kim, ; E., S.; Mehlhorn, ; Baste, ; Clayburgh, ; Lipworth, ; Resteghini, C; Shara, ; Fujii, ; Zhang, ; Stokes, ; Lawrence, ; Khaliq, ; Melillo, ; Shire, | |
| Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials | 1-gen-2019 | De, Cecco; Serafini, ; M., S.; Canevari, ; Penso, ; Nicolai, ; Castelnuovo, ; Benazzo, ; Sponghini, ; Orlandi, ; Vischioni, ; Piazza, ; Resteghini, C; Licitra, ; Bossi, | |
| The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) | 1-gen-2021 | Resteghini, C; Castelnuovo, ; Paolo, ; Nicolai, ; Piero, ; Orlandi, ; Ester, ; Bossi, ; Paolo, ; Vischioni, ; Barbara, ; Schreiber, ; Alberto, ; Iacovelli, ; Nicola, Alessandro; Battaglia, ; Paolo, ; Mattavelli, ; Davide, ; Facchinetti, ; Nadia, ; Gambazza, ; Simone, ; Calareso, ; Giuseppina, ; Ravanelli, ; Marco, ; Facco, ; Carla, ; Tartaro, ; Tiziana, ; Sponghini, ; Andrea, Pietro; Pagella, ; Fabio, ; Mariani, ; Luigi, ; Licitra, ; Lisa, F. | |
| Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience | 1-gen-2016 | Granata, ; Bossi, ; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Fallai, ; Guzzo, ; Infante, ; Locati, ; Miceli, ; Mariani, ; Licitra, | |
| Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer | 1-gen-2017 | Orlandi, ; Infante, ; Granata, ; Iacovelli, ; Miceli, ; Cavallo, ; Alfieri, ; Bergamini, ; Resteghini, C; Galbiati, ; Locati, ; Tana, ; Naimo, ; Fallai, ; Licitra, ; Bossi, |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1974
Data di pubblicazione
- 2020 - 202490
- 2010 - 20191238
- 2000 - 2009534
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY121
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...119
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE96
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY56
- ANNALS OF ONCOLOGY46
- HEPATOLOGY43
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng695
- ita24
- und6
Accesso al fulltext
- no fulltext1921
- reserved51
- open2